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Abstract. Expression of the adenovirus E1A oncogene 
stimulates both cell proliferation and p53-dependent 
apoptosis in rodent cells, p53 implements apoptosis in 
all or in part through transcriptional activation of bax, 
the product of which promotes cell death. The adenovi- 
rus E1B 19K product is homologous in sequence and in 
function to Bcl-2, both of which bind to and inhibit the 
activity of Bax and thereby suppress apoptosis. The 
E1B 19K protein also interacts with the nuclear lamins, 
but the role of this interaction in the regulation of apop- 
tosis is not known. Lamins are, however, substrates for 
members of the interleukin-ll3--converting enzyme 
(ICE) family of cysteine proteases that are activated 
during apoptosis and function downstream of Bcl-2 in 
the cell death pathway. Lamins are degraded during 
E1A-induced p53-dependent apoptosis. Lamin A and 
C are cleaved into 47- and 37-kD fragments, respec- 
tively, and the site of proteolysis is mapped to a con- 
served aspartic acid residue at position 230. The cleav- 
age of lamins during apoptosis is consistent with the 
activation of an ICE-related cysteine protease down- 
stream of p53. No lamin protease activity was detected 
in cells expressing the E1B 19K protein, indicating that 
19K functions upstream of protease activation in inhib- 
iting apoptosis. Substitution of the aspartic acid at the 
cleavage site produced a mutant lamin protein that was 
resistant to proteolysis both in vitro and in vivo. Ex- 
pression of uncleavable mutant lamin A or B attenu- 
ated apoptosis, delaying cell death and the associated 
DNA fragmentation by 12 h. Mutant lamin expressing 
cells failed to show the signs of chromatin condensation 
and nuclear shrinkage typical of cell death by apoptosis. 
Instead, the nuclear envelope collapsed and the nuclear 
lamina remained intact. However, the late stage of apop- 
tosis was morphologically unaltered and formation of 
apoptotic bodies was evident. Thus, lamin breakdown 
by proteolytic degradation facilitates the nuclear events 
of apoptosis perhaps by facilitating nuclear breakdown. 
OPTOSIS is a genetically regulated mechanism of cell 
death  commonly observed  during  development, 
disease,  and  viral  infections,  and  is  required  to 
maintain  homeostasis  in  multicellular  organisms  (Raft, 
1992; White,  1996). The  cellular  morphology associated 
with the apoptotic process has been well documented and 
is characterized by chromosome condensation, membrane 
blebbing, formation of apoptotic bodies, and DNA frag- 
mentation  (Wyllie,  1980). The molecular mechanisms of 
apoptosis are just beginning to be understood. Several ver- 
tebrate, invertebrate,  and viral genes and gene products 
that regulate apoptosis have been identified (White, 1996). 
The regulation of apoptosis during adenovirus infection 
and transformation has been well studied. The adenovirus 
E1A oncogene promotes cellular DNA replication  (Mo- 
ran, 1993), which is countered by a cellular response mani- 
fested by the  induction  of p53,  accumulation  of which 
causes apoptosis. As a result, productive infection or effec- 
tive  transformation  by E1A  is  impaired  (White,  1995; 
Address all correspondence to Eileen White, Center for Advanced Bio- 
technology and Medicine, 679  Hoes Lane, Piscataway, NJ  08854.  Tel.: 
(908) 235-5329. Fax: (908) 235-5318. e-mail: ewhite@mbcLrutgers.edu 
White et al., 1991, 1994). Apoptosis can be overcome by 
the coexpression of EIA with a second gene product, ei- 
ther the adenovirus E1B 19K protein or the human pro- 
tooncogene bcl-2 (Chiou et al.,  1994a; Rao et al.,  1992). 
E1B 19K is the adenovirus homologue of Bcl-2,  as both 
overcome apoptosis and  possess limited  amino  acid  se- 
quence similarity  (Chiou et al., 1994b). 
Apoptosis induced by E1A is p53 dependent, as domi- 
nant interfering mutants of p53 can cooperate with EIA to 
transform primary baby rat kidney (BRK)  1 cells (Debbas 
and White,  1993). E1A and a temperature-sensitive mu- 
tant of p53 (Vail35) effectively transform BRK cells at the 
restrictive temperature of 38°C, but cells rapidly undergo 
apoptosis when incubated at 32°C (the permissive temper- 
ature) when p53 is predominantly wild type. E1B 19K ex- 
pression completely inhibits  the induction of apoptosis by 
p53 (Debbas and White,  1993). Furthermore,  p53-medi- 
ated transactivation of the Bax gene product, a death-pro- 
moting  member  of the  Bcl-2 family,  is  one  mechanism 
1.  Abbreviations used  in  this paper.  BRK, baby rat  kidney; GST,  glu- 
tathione-S-transferase; ICE, interleukin-ll3--converting enzyme; IL, inter- 
leukin; PARP, poly(ADP-ribose) polymerase; TLCK, Tos-Lys-CH2CI. 
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cells (Han et al., 1996a). Factors and events downstream of 
Bax are yet to be elucidated. 
Studies in  the  nematode Caenorhabditis  elegans  have 
been greatly instrumental in establishing the genetic deter- 
minants underlying programmed cell death. Induction of 
cell death in C.  elegans is controlled by ced-3  and ced-4 
(Ellis et al., 1991). The Ced-3 gene product is essential for 
activating the death program in C. elegans (Ellis and Hor- 
vitz,  1986),  and cloning and sequencing of the gene re- 
vealed  homology  to  interleukin-II3-converting  enzyme 
(ICE)  (Yuan et al.,  1993).  ICE is a mammalian cysteine 
protease that recognizes and cleaves prointerleukin (IL)-l13 
to its active form at aspartate residues (Thornberry et al., 
1992). Although overexpression of ICE induces apoptotic 
events in Rat-1  cells (Miura et al.,  1993),  ICE-deficient 
mice develop normally with no defects in apoptosis (Kuida 
et al., 1995; Li et al., 1995).  Numerous mammalian ICE- 
related  proteases  whose  expression  induces  apoptosis 
have since been identified (Fraser and Evan, 1996). These 
include Nedd-2/ICH-1  (Kumar et al.,  1994; Wang et al., 
1994),  CPP32/Yama/Apopain (Fernandes-Alnemri et al., 
1994; Nicholson et al., 1995; Tewari et al., 1995), Tx/ICH- 
2/ICErel.ii (Faucheu et al., 1995; Kamens et al., 1995; Mun- 
day et al., 1995),  ICErel-III (Munday et al., 1995),  Mch-2 
(Fernandes-Alnemri  et  al.,  1995a),  ICE-LAP3/Mch-3/ 
CMH-1  (Duan  et  al.,  1996; Fernandes-Alnemri  et  al., 
1995b), and FLICE/MACH (Boldin et al., 1996; Muzio et al., 
1996).  Furthermore,  the  activation  of ICE-related  pro- 
teases is downstream of Bcl-2 in the molecular ordering of 
the apoptosis pathway (Chinnaiyan et al.,  1996).  Clearly, 
ICE-related proteases are an important component of the 
apoptotic machinery. 
Identifying the downstream substrates is the key to un- 
derstanding the role of these proteases in vivo. The nu- 
clear enzyme poly(ADP-ribose) polymerase (PARP) is a 
substrate of a protease resembling ICE (priCE) in a cell- 
free in vitro system (Lazebnik et al., 1994).  Both PARP 
and IL-l[3-deficient null mice develop normally with only 
specific defects in  the  inflammation process  with IL-113 
loss (Zheng et al., 1995) and epidermal hyperplasia in the 
absence of PARP (Wang et al., 1995). This suggests that 
multiple downstream substrates  of the  ICE-related cys- 
teine proteases are responsible for bringing about differ- 
ent apoptotic events. Other substrates identified include 
lamins A, B, and C, the 70-kD protein component of the 
U1  small  ribonucleoprotein,  a-fodrin,  topoisomerase  I, 
and [3-actin, but the role of any of these substrates in apop- 
tosis is not yet clear (Fraser and Evan, 1996; Martin and 
Green, 1995). 
It is attractive to think that proteolytic cleavage of the 
nuclear lamins by ICE  family members  plays a  role  in 
some of the events associated with apoptosis. The lamins 
are intermediate filament proteins that constitute the main 
structural components of the lamina underlying the inner 
nuclear membrane and serve to organize the chromatin 
(McKeon, 1991). Lamins A and C are alternatively spliced 
products of the same gene and differ only in their carboxy 
terminus. The B-type lamins are distinct but structurally 
related proteins (Nigg, 1992). Both A- and B-type lamins 
are characterized by an a-helical rod domain to enable as- 
sembly into filaments, a nuclear localization sequence to 
direct them to the nucleus, and a carboxy-terminal CAAX 
box isoprenylation sequence for nuclear membrane target- 
ing (McKeon, 1991).  Lamin disassembly at the onset of 
mitosis occurs by hyperphosphorylation at  specific sites 
flanking the a-helical rod domain by p34  ~c2 kinase (Peter 
et al., 1990; Ward and Kirschner, 1990).  Lamin polymer- 
ization is required  for nuclear reassembly after mitosis, 
suggesting that the lamins play an important role in nu- 
clear organization (Heald and McKeon, 1990; Nigg, 1992). 
However, during apoptosis, lamin disassembly is accom- 
plished through  cleavage  by a  protease  related  to  ICE 
(Earnshaw, 1995; Lazebnik et al., 1995). 
Lamin proteolysis during apoptosis has been reported 
from several cell types. Etoposide-induced apoptosis  in 
HL-60 cells is accompanied by extensive protein degrada- 
tion and diminished levels of lamin B (Kaufmann, 1989). 
Similarly, activation-driven cell death of T cells causes sol- 
ubilization  of  the  nuclear  lamins  (Ucker  et  al.,  1992). 
Lamin degradation is also observed in apoptosis induced 
by serum starvation of ras transformed primary rat em- 
bryo cells where lamin A and B are degraded into a 46-kD 
fragment in parallel with chromatin condensation (Ober- 
hammer et al., 1994). Lamin B1 degradation in apoptotic 
thymocytes was reported to precede  the onset of DNA 
fragmentation (Neamati et al., 1995). Proteolysis of lamin 
A into a 45-kD fragment has been demonstrated using cell 
free extracts in vitro, suggesting that an ICE-like protease 
is responsible (Lazebnik et al.,  1995).  Lamin cleavage in 
vitro is inhibited by protease inhibitors like Tyr-Val-Ala- 
Asp-CH2CI  (YVAD-cmk)  and  Tos-Lys-CH2C1  (TLCK) 
(Lazebnik et al., 1995). 
The contribution of lamin degradation to cell death by 
apoptosis remains  obscure.  We  have demonstrated that 
lamin  cleavage  occurs  during p53-dependent  apoptosis, 
and the  site of lamin cleavage was identified as  a  con- 
served aspartic acid residue at position 230. Alteration of 
this aspartic acid to an alanine by site-directed mutagene- 
sis produced a mutant lamin protein that was resistant to 
proteolysis in vivo and in vitro. Ectopic expression of an 
uncleavable mutant of lamin A  or B caused a significant 
delay in the onset of apoptosis. Analysis of the ultrastruc- 
ture and morphology of these cells revealed the require- 
ment of lamin proteolysis in bringing about some of the 
nuclear  events  associated  with  apoptosis.  The  mutant 
lamin-expressing cells displayed a delay in nuclear shrink- 
age and an absence of normal chromatin condensation. In- 
stead, the nuclei collapsed in on themselves while retain- 
ing an intact lamina and nuclear envelope. However, the 
late stages of apoptosis are similar to the parental cells as 
seen  by  the  formation of apoptotic  bodies.  Thus,  pro- 
teolytic cleavage of lamins in vivo is required for normal 
progression of apoptotic cell death. 
Materials and Methods 
Cloning and Plasmid Constructions 
The lamin A  eDNA was reverse transcription-PCR cloned using RNA 
from Hela cells as the template. Specific primers incorporating BstXI and 
NotI sites were used at the 5' and 3' end, respectively, to include initiation 
and termination sites. The eDNA was cloned into the BstXI/NotI sites of 
the pRcCMV vector (Invitrogen, San Diego, CA). The lamin B eDNA 
(Pollard et al., 1990) was obtained in the pBLUESCRIPT vector from Dr. 
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sequence of these constructs was verified, and they were used as templates 
for all subsequent cloning and mutation steps. 
Glutathione-S-transferase (GST) fusion protein of a fragment of lamin 
A (GST LA220-390) was constructed by PCR cloning from the full-length 
lamin A template using specific primers with EcoRI and XhoI sites engi- 
neered to clone in frame with the GST protein in the pGEX4T-1 vector 
(Pharmacia Fine  Chemicals, Piscataway, N J). The  primers used were: 
LA220- ATTCTI'GAATrCGCGCCGTCATGAGACCCGA  and LA3~0r- 
AqTATTCTCGAGGGACAGGCGTAGCCTCTC.  GST LB220-390  was 
constructed  by  the  same  strategy  into  the  EcoRI/XhoI  sites  of  the 
pGEX4T-1  vector.  The  primers  used  were:  LB220- ATTc'VrGAAT- 
TCAGGAAGCATGAAACGCGC  and  LB390r-  AqTATTCTCGAG- 
CAGCTTCAACCTCTCTFC.  The D ---> A mutation was created using a 
long oligonucleotide at the 5' end to make a single base substitution and 
to incorporate the amino acid change. This was used in conjunction with 
the 3' oligonucleotide listed above to prime the synthesis of a PCR prod- 
uct that was cloned into the EcoRI/XhoI sites of the pGEX4T-1 vector. 
The  primers  used  were:  LA220 mut-  Aqq'CTI'GAATTCGCGCCGT - 
CATGAGACCCGACTGGTGGAGATTGCCAAT  and  LB220  mut- 
A TTCTTG AA TI'CA GG  AA GCA  TG  AAA CGCGCTTGGT A G A GG  T- 
GGCT. 
The full-length lamin A and lamin B mutants were constructed with the 
same  basic  strategy.  A  unique  restriction site  (BspHI)  was  identified 
within 40 bases of the aspartate residue to be changed to alanine. Oligonu- 
cleotides were designed from the ATG of the gene including an XmaI site 
upstream to be in frame with a myc or FLAG epitope tag. The primer at 
the 3' end included the termination site followed by an XhoI site. Internal 
primers  had  a  single base  substitution to  incorporate  the  amino  acid 
change from aspartate to alanine. PCR was performed to generate two 
fragments of each gene that were ligated at the unique BspHI site to re- 
generate the full-length product. The full-length lamin A and lamin B cD- 
NAs containing the single base substitution were cloned into the KpnI/ 
XhoI sites of pCEP4 and pcDNA3 (Invitrogen) vectors, respectively. The 
myc tag has been previously reported (Han et al., 1996a), and the FLAG 
tag amino acid sequence corresponded to DYKDDDDK. Standard PCR 
conditions and protocols were used in all cases. The constructs were veri- 
fied for sequence and presence of the mutation confirmed by using an au- 
tomated sequencer (ABI 373; Perkin-Elmer Corp., Foster City, CA). 
Cell Lines, Transfections, and Viability and DNA 
Fragmentation Assays 
An1, 19K1, 19K2, p53A, and 4P cell lines have been previously described 
(Debbas and White, 1993). The E1A plus p53 (Val135) transformed BRK 
line p53A was transfected by electroporation with a hygromycin-resistant 
vector (pCEP4)  or  a  corresponding mutant  lamin A-carrying plasmid 
(pCEP4-LA rout). Transformants were screened by Western blotting us- 
ing an anti-myc epitope antibody. Three independent clones (LA-1, LA-2, 
and  LA-3) and two vector controls (Vhl  and Vh2) were derived and 
maintained at 38°C. LA-1, LA-2, and Vhl were then transfected with a 
neo vector (pcDNA3) or a plasmid carrying mutant lamin B with a FLAG 
epitope tag (pcDNA3-LB mut). Cell lines expressing neither protein, ei- 
ther lamin A or lamin B, and both lamin A and lamin B were screened as 
described above using anti-myc and -FLAG mAbs by Western blotting. 
All cell lines were maintained in DME with 5% FBS and maintained at 
38°C (restrictive temperature) unless otherwise mentioned. Viability as- 
sessments were made by trypan blue exclusion as described previously 
(Chiou et al., 1994a). Low molecular weight DNA was extracted from the 
vector control cell line and two representative mutant lamin-expressing 
cell lines after incubating at 38°C (0 h) and at 320C for 8, 16, 24, and 48 h 
by the method of Hilt  (1967)  with minor modifications (White et al., 
1984). Equal volumes of the Hirt supernatant were resolved on a 1% aga- 
rose gel, and degraded DNA was visualized by staining with ethidium bro- 
mide. 
Western Blotting and Antibodies 
Extracts were obtained from subconfluent cultures, and the protein con- 
centration was determined. 40 I~g of each protein sample was subjected to 
SDS-PAGE and semidry blotted onto nitrocellulose membranes. Subse- 
quent to incubation with appropriate primary and secondary antibodies, 
immune complexes were detected by enhanced chemiluminescence ac- 
cording to the manufacturer's instructions (ECL; Amersham Corp., Ar- 
lington Heights, IL). The lamin A/C antibodies (McKeon et al.,  1988) 
were a kind gift of Dr. Frank McKeon (Harvard Medical School, Boston, 
MA), and the murine anti-p53 antibody (pAb248) was generously pro- 
vided by Dr. Arnold Levine (Princeton University, Princeton, N J). Anti- 
bodies directed to lamin B  (Matritech, Inc., Cambridge, MA), the myc 
epitope  (Calbiochem-Novabiochem Corp., La  Jolla,  CA),  the  FLAG 
epitope (Scientific Imaging Systems, New Haven, CT), E1A (M73) (Calbi- 
ochem-Novabioehem Corp.),  GST  (Santa  Cruz  Biotechnology,  Santa 
Cruz, CA), PARP (C-2-10) (Enzyme Systems Products, Dublin, CA), and 
actin (Amersham Corp.) were purchased and used according to the manu- 
facturer's specifications. 
In vitro Proteolysis  Assay 
Cytosolic extracts of the cells to be assayed for protease activation were 
prepared as described (Nicholson et al., 1995). In brief, cells at 38°C (0 h, 
nonapoptotic) or after incubation at 32°C (apoptotic) were harvested with 
medium and washed with PBS. All cells were counted and resuspended in 
ice-cold lysis  buffer  containing  10  mM  Hepes,  2  mM  EDTA,  0.1% 
CHAPS, 5 mM DTT, 1 mM PMSF, 20 ~g/ml leupeptin, 10 ixg/ml pepstatin 
A, and 10 p,g/ml aprotinin at 108 cells per ml. Lysates were repeatedly 
spun at 12,000 g for 10 rain to remove cellular debris, and aliquots of the 
supernatant were stored under liquid nitrogen. To assess the kinetics of 
lamin cleavage in the time-course experiments, the extracts were equal- 
ized for protein concentration. 
GST LA220-390, GST LB220-390,  and their respective D --~ A mutants 
were purified from BL21 Escherichia coli after induction with isopropyl- 
thio-13-o-galactoside.  Purification was achieved on glutathione-Sepharose 
according to the manufacturer's instructions (Pharmacia Fine Chemicals). 
Purified protein was eluted from the beads and quantitated. Cytosolic ex- 
tracts were mixed with purified proteins at a concentration of 0.5 }xg pro- 
tein  per  10  p,l of extract  and  incubated at  37°C.  The  reactions were 
stopped by the addition of Laemmli sample buffer and boiling. An aliquot 
taken before incubation represented the 0-h time point. Samples were re- 
solved on SDS-PAGE gels, transferred to nitrocellulose membranes, and 
blotted using anti-GST antibodies as described above. 
Ultrastructural Analysis 
Samples for EM were obtained from a mutant lamin A and B-expressing 
cell line (LA1-LB1) and a corresponding vector control line (Vhl-nl) at 
38°C and after 24 h  at 32°C.  Cells were processed, viewed, and photo- 
graphed as previously described (Rao et al., 1992). 
Indirect Immunofluorescence 
Cells were plated at low density onto glass coverslips. The cells, incubated 
either at 38°C or 32°C, were fLxed and processed for indirect immunofluo- 
rescence as described previously (White and Cipriani, 1989). Endogenous 
lamin  A/C,  the  myc  epitope-tagged  mutant  lamin  A,  or  the  FLAG 
epitope-tagged mutant lamin B were visualized using the primary anti- 
bodies described earlier and a rhodamine-conjugated anti-mouse second- 
ary antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, 
PA). The cells were simultaneously stained with Hoechst dye for DNA. 
The terminal phenotype of the cells was assessed by labeling with Hoechst 
dye in vivo and harvesting the floating cells in the medium after 28 h at 
32°C. The cells were then washed with PBS and visualized by wet mount- 
ing onto slides. All slides were examined and photographed by a micro- 
scope with epifluorescence optics (FXA; Nikon Inc., Garden City, NY). 
Results 
Degradation of  Nuclear Lamins during 
p53-dependent Apoptosis 
Induction of apoptosis by adenovirus EIA has been previ- 
ously characterized  and  shown to be mediated  by wild- 
type p53 (Chiou et al.,  1994a; Debbas and White,  1993; 
Sabbatini et al., 1995a, b). Primary BRK cells transformed 
by EIA and temperature-sensitive p53 (Va1135) prolifer- 
ate at the restrictive temperature of 38~C but undergo apop- 
tosis at the permissive temperature of 32°C when p53 is 
predominantly in the wild-type conformation (Debbas and 
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moting protein Bax by p53 is one mechanism for the in- 
duction  of  apoptosis  in  these  cells  (Han  et  al.,  1996a). 
Events downstream of Bax are poorly understood. To un- 
derstand the role of cysteine proteases, if any, we investi- 
gated the status of nuclear lamins in these cells. Proteolysis 
of lamins has been reported from a variety of systems, and 
lamins represent a  ubiquitous  substrate of proteases acti- 
vated  during  apoptosis  (Earnshaw,  1995).  We  evaluated 
whether lamin proteolysis occurred during p53-dependent 
apoptosis. 
Anl is a BRK cell line transformed with E1A and tem- 
perature-sensitive p53 (Va1135).  These cells proliferate at 
the restrictive temperature of 38°C but undergo apoptosis 
at the  permissive temperature of 32°C  when p53  is wild 
type. 19K1 and 19K2 are identical E1A plus p53 (Va1135) 
transformed BRK cell lines  that  stably express the  E1B 
19K protein and thus are protected from apoptosis. 4P, a 
BRK line transformed with E1A and E1B, serves as a con- 
trol.  Lamins A  and C  are essentially identical  except for 
their carboxy termini. Both proteins are recognized by a 
COOH-terminal mAb and seen as 73- and 63-kD proteins, 
respectively (Fig. 1). 
Western blot analysis of extracts from cells undergoing 
p53-dependent apoptosis revealed the degradation of the 
nuclear lamins with increasing time at the permissive tem- 
perature when p53 is wild type (Fig. 1). Anl cells began to 
show morphological signs of apoptosis between 12 and 16 h 
of incubation at 32°C (data not shown). Degradation prod- 
ucts of lamin A  and C were seen as two discrete bands of 
~47 and 37 kD, respectively, and appeared ~10 h after in- 
cubation at 32°C. These results are consistent with findings 
published previously and indicate a cleavage site near the 
center of the lamin A  protein. Lamin B degradation prod- 
ucts were not as evident since the levels of lamin B in BRK 
cells were low (Fig. 1). There was no obvious degradation 
of lamin A, B, or C  in the cells expressing the EtB  19K 
protein where  apoptosis was inhibited  (Fig.  1).  Further- 
more, lamin degradation was observed before nonspecific 
proteolysis of E1A and murine p53 occurring in Anl cells 
after 24  and  48  h  of incubation  at 32°C,  at which  point 
overall cellular degradation occurred. 
After 24 h at 32°C, morphological changes associated with 
late stage apoptosis typified by chromatin condensation was 
observed (Fig. 2).  Concomitantly, staining the same cells 
with the lamin A/C antibody showed disappearance of the 
lamina and was consistent with lamin degradation (Fig. 2). 
E1B  19K-expressing cells incubated  at 32°C  showed  no 
obvious changes  in  morphology or  lamin  staining  when 
compared with the cells incubated at 38°C (Fig. 2). 
Mapping of the Lamin Cleavage Site 
The  ICE  family of cysteine  proteases  is  activated upon 
various forms of stimuli resulting in the induction of apop- 
tosis. These proteases recognize and cleave at a conserved 
aspartic  acid  residue  in  the  P1  position  of a  consensus 
cleavage site in all known substrates. This is in the context 
of other flanking amino acids, which possibly lends speci- 
ficity (Martin and Green, 1995). PARP, a substrate of var- 
Figure  1.  Lamins  are  de- 
graded  during  EIA-induced 
p53-dependent  apoptosis. 
Western  blot  analysis  of 
lamin  degradation  in  Anl, 
19K1, 19K2, and 4P cell lines 
at the restrictive  and permis- 
sive temperatures. Total cell 
extracts  were prepared from 
Anl  cells  at  the  restrictive 
temperature (0 h)  and  after 
incubation  for 4, 10, 24, and 
48 h  at the permissive  tem- 
perature.  Extracts  for  the 
19K1,  19K2, and  4P  lines 
were prepared at the restric- 
tive  temperature  and  after 
incubation  for 4,  10,  24,  48, 
and  72  h  at  the  permissive 
temperature.  Western  blots 
were probed with antibodies 
specific for lamin A/C, lamin 
B,  murine  p53  (pAb  248), 
and E1A (M73). 
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pearing lamina during  p53-dependent 
apoptosis.  An1  and  19K1 cells  were 
stained  by  indirect  immunofluores- 
cence for lamin A/C and by Hoechst 
dye for DNA at 38°C (restrictive  tem- 
perature) or after 24 h at 32°C (permis- 
sive  temperature).  Anl  cells  at  32°C 
were photographed in two planes of fo- 
cus to clearly show the cells undergoing 
apoptosis  as  evidenced  by chromatin 
condensation  (arrows). 
ious cysteine proteases activated during apoptosis, is cleaved 
at an aspartate in the context of its cleavage site DEVDgG 
(Lazebnik et al.,  1994;  Nicholson  et  al.,  1995).  Lamin A 
contains two putative cleavage consensus sites, the aspar- 
tic acid residues at position 230 and 446 in the context of 
EVDNG and EIDSG, respectively. However, the appear- 
ance of 47- and 37-kD bands in the Western blot (Fig. 1) 
corresponding to lamin A  and C  using a  COOH-terminal 
antibody indicated  the  presence of a  single cleavage site 
consistent  with  that  at Asp230.  Furthermore,  this  aspar- 
tate  is  conserved  among  lamins  from  human,  mouse, 
chicken, Xenopus, and Drosophila as also lamin B  and vi- 
mentin  (Fig.  3  a).  To test  if Asp230  was indeed  a  valid 
cleavage site recognized by a cysteine protease, we devised 
an in vitro cleavage assay. 
Fragments  of  human  lamin  A/C  and  lamin  B  from 
amino acids 220-390  (which included  the putative cleav- 
age  site)  were  generated  as  fusion  proteins  with  GST 
(GST LA220-390 and GST LB220-390)  (Fig. 3 b). These 
fusion proteins were purified over glutathione-Sepharose 
beads. When cleaved at the consensus site, a GST protein 
product of ~27  kD would  be generated, which could be 
conveniently  assayed by Western  blotting  with  an  anti- 
GST antibody. A  corresponding substitution mutation re- 
sulting  in  the  change of the  P1  aspartate  to alanine  was 
also generated  (GST LA220-390 D--~A mutant and GST 
LB220-390 D--~A mutant) (Fig. 3 b). If the site were rec- 
ognized by a  cysteine protease, the change would render 
the  D---~A mutant  resistant  to cleavage.  Cytoplasmic ex- 
tracts  from E1A  plus  p53  (Va1135)  transformed  cells  at 
38°C  (nonapoptotic)  and  after  14  h  at  32°C  (apoptotic) 
were used to assay for protease activity. The lamin frag- 
ment-GST  fusion  proteins  described  above  were  incu- 
bated with these extracts at 37°C for increasing lengths of 
time and Western blotted using an anti-GST antibody to 
detect cleavage products, if any. As seen in Fig. 4, a  and c, 
protease activity was detected in the cytoplasmic extracts 
of apoptotic cells with  the  capacity to  cleave the  GST- 
lamin fusion  proteins  and  generated  a  cleavage product 
corresponding to the expected size of ~27 kD migrating 
with GST alone.  An increase in  the  amount of cleavage 
product formed was observed with increasing time, consis- 
tent  with  an enzymatic activity. Furthermore,  the  D--->A 
mutant of the same protein was resistant to cleavage, con- 
firming the site of proteolysis to be VEID~N for lamin A 
and VEVD~S for lamin B. 
Activation of  ICE-related Proteases during Apoptosis 
and Inhibition of  Activation by E1B 19K Expression 
The  lamin  cleavage  activity  appeared  in  the  apoptotic 
32°C extract but not in the nonapoptotic 38°C  extract of 
Anl  cells,  suggesting that  protease activation lies down- 
stream of p53 (Fig. 4, a and c). No protease activity was de- 
tected in extracts from cells stably expressing the E1B 19K 
protein incubated either at 38  ° or 32°C  (Fig. 4, b  and d). 
The  E1B  19K protein  expression  also prevents the  pro- 
cessing of CPP32 and cleavage of PARP in CHO cells in- 
fected with adenoviruses (Boulakia et al., 1996). The ab- 
sence  of lamin cleavage  activity in  E1B  19K-expressing 
cells observed here further reinforces the role of the E1B 
19K protein as an inhibitor of apoptosis and places it up- 
stream of protease activation in the apoptotic pathway. 
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Figure 3.  Location of lamin 
cleavage  sites  and  cleavage 
site mutants.  (a) Amino acid 
sequence  alignment  of 
lamins from different  species 
and  human  vimentin  from 
amino acids 207-248 that in- 
cludes  the putative cleavage 
site. The aspartate at position 
230  is  marked by an  arrow 
and  constitutes  the  site  of 
cleavage. The mutations used 
to change  this  aspartate are 
indicated. (b) Main structural 
features of lamin A are indi- 
cated.  Schematic representa- 
tion  of the  GST  constructs 
used  to  generate  fragments 
of lamins  and their mutants 
to assay for in vitro cleavage 
and  protease activity.  Open 
regions  correspond  to  GST 
sequences  in the fusion pro- 
tein, and the lamin sequences 
are  indicated  by  closed 
boxes. The exact location  of 
the mutation is represented. 
Kinetics of the Activation of  Lamin Proteases during 
p53-dependent Apoptosis 
The  temperature-sensitive p53  (Vail35)  protein  is  cyto- 
plasmic when in the mutant conformation at the restrictive 
temperature and translocates to the nucleus at the permis- 
sive temperature when p53 assumes the wild-type confor- 
mation (Martinez et al., 1991; Michalovitz et al., 1990). In 
the  EIA plus p53  (Va1135)  transformed BRK cells,  this 
process occurs within 3-4 h of incubating the cells at 32°C 
along with transcriptional induction of the p53-responsive 
genes p21/waf-1/cipl and Bax (Han et al., 1996a;  Sabbatini 
et al.,  1995b).  However, the  morphological changes  and 
loss of viability associated with apoptosis began at ~12 h 
after incubating the cells at 32°C (data not shown). In un- 
derstanding the kinetics of events before the final execu- 
tion  of apoptosis, biochemical processes  downstream of 
Bax induction may be important. Using the in vitro lamin 
proteolysis assay, we sought to determine the kinetics of 
lamin cleavage and thereby the kinetics of ICE-like cys- 
teine protease activation during p53-dependent apoptosis. 
Activation of lamin proteases was assessed in cytoplas- 
mic extracts obtained from An1  and 19K1 cell lines. Ex- 
tracts were made from cells incubated at either the restric- 
tive temperature or for increasing times at the permissive 
temperature  and  were  equalized  for  protein  concentra- 
tion. These extracts were incubated with GST-LA220-390 
and GST-LA220-390 (D--~A mutant) for 1 h  at 37°C and 
Western  blotted  with  an  anti-GST  antibody  to  detect 
cleavage products. Protease activity was detected at 8 h af- 
ter incubation at 32°C, as seen by the cleavage product at 
~27 kD (Fig. 5 a). Peak activity was observed after 12 h at 
the permissive temperature with no detectable activity re- 
maining by 24 h. The loss of lamin protease activity at 24 h 
was likely due to the extensive cell death and thereby cell 
degeneration that had occurred by that time (Fig. 5 a). As 
expected, no lamin cleavage activity was observed when 
the cleavage site Asp230 (D---~A) mutant was used as the 
substrate (Fig. 5 a). Once again, E1B 19K-expressing cells 
showed no detectable lamin protease activity at any time 
of incubation  at  the  permissive temperature  (Fig.  5  b). 
These results indicate that lamin protease activation was 
downstream of p53 and possibly occurred as a direct or in- 
direct consequence  of Bax induction.  The E1B  19K pro- 
tein inhibits lamin protease activation by acting upstream, 
likely through interaction with and functional antagonism 
of Bax. Thus, both the in vivo and in vitro lamin cleavage 
results suggest that in the time line of events leading to the 
final execution of the apoptotic program, lamin proteolysis 
is a significantly early step occurring before nuclear break- 
down and loss of cell viability. 
Prevention of  Lamin Cleavage  Attenuates Apoptosis 
In Vivo 
Having characterized the activity of a lamin cleaving pro- 
tease  during  p53-dependent  apoptosis  and  the  site  of 
cleavage in vitro, we sought to address the significance of 
lamins  as substrates  in  vivo. The critical role of nuclear 
events  during  apoptosis  is  well  established  (Earnshaw, 
1995). Even though the nuclear envelope remains intact, the 
chromatin  of cells  undergoing  apoptosis  condenses,  col- 
lapsing  against  the  nuclear  periphery,  and  subsequently 
buds off into smaller apoptotic bodies (Wyllie, 1980).  This 
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dent apoptosis, and inhibition by EIB 19K expression. Western 
blot of GST-mini lamin fusion proteins with an anti-GST anti- 
body. (a and c) Extracts of Anl cells at 38°C (restrictive tempera- 
ture,  nonapoptotic)  and  32°C  (permissive  temperature,  apop- 
totic) were incubated with GST LA 220-390, GST LB 220-390, 
and their  respective  D--->A mutants  for 0,  30, and 60 min and 
Western blotted with anti-GST antibodies. The cleavage product 
comigrates with the GST protein. (b and d) C3rtoplasmic extracts 
from E1B 19K--expressing cells (19K1) at 38  ° and 32°C were incu- 
bated with the GST-mini lamin fusion proteins and their mutants 
for 0, 30, and 60 min before Western blotting with anti-GST anti- 
bodies. The position of the 31-kD marker is indicated in all blots. 
is  an unmistakable  hallmark  of apoptosis  observed in a 
variety  of  systems.  Inhibition  of  lamin  proteolysis  in 
vitro  by the  addition  of the  protease  inhibitor  TLCK re- 
suited in the arrest of the nuclear changes at the condensed 
chromatin stage, with the chromatin forming a continuous 
rim around the nuclear envelope  (Lazebnik et al.,  1995). 
However,  TLCK  is  a  nonspecific protease  inhibitor  and 
likely inhibits more than merely lamin cleavage in a  cell- 
free system. 
Figure 5.  Kinetics  of the  activation  of lamin  proteases  during 
p53-dependent apoptosis. (a) Extracts from Anl cells at the re- 
strictive  temperature (0 h) and after 4, 8, 12, 16, and 24 h at the 
permissive temperature were incubated with the GST LA 220- 
390  and GST LA 220-390  (D---rA) fusion proteins for 1 h  and 
Western blotted with anti-GST antibodies. The 31-kD marker is 
shown. (b) Extracts from EIB 19K-expressing cells at the restric- 
tive temperature (0 h) and after 4, 8, 12, 16, and 24 h at the per- 
missive temperature were incubated with the fusion proteins for 1 h 
before Western blotting with anti-GST antibodies. Generation of 
the lamin cleavage product is indicated by the presence of the 27-kD 
band. 
The cleavage site mutant of human lamin A  was recon- 
stituted into the full-length lamin A  protein and expressed 
under the control of a  cytomegalovirus promoter.  A  myc 
epitope tag allowed the recombinant, uncleavable lamin A 
to be distinguished  from the endogenous lamin A, and a 
hygromycin drug resistance marker allowed for the selec- 
tion of stable cell lines. Three cell lines were derived from 
the parental E1A plus p53 (Vail35) transformed cell line, 
p53A.  The  myc-tagged mutant  lamin  A  protein  was de- 
tected in cell lines LA-1, LA-2, and LA-3 by Western blot 
analysis (Fig. 6 a). Vhl and Vh2 are equivalent vector con- 
trol cell lines selected at the same time by transfecting the 
p53A cell line with an empty hygromycin vector (pCEP4). 
The mutant lamin A  in all three cell lines localized to the 
nuclear periphery and was indistinguishable from endoge- 
nous  lamin  A  in  proliferating  cells  at  38°C  (see  below). 
Mutant  lamin A  expression  did not alter  the rate  of cell 
proliferation, and lamin disassembly was observed in cells 
undergoing mitosis (data not shown), indicating that lamin 
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Figure 6.  Effect of the expression of mutant lamin A in vivo. (a) 
Levels of expression  of mutant  lamin  A.  Three  independent 
clones were selected  to express  mutant lamin A  as seen by the 
Western blot using anti-myc epitope antibody.  Vhl and Vh2 are 
vector control lines selected at the same time for hygromycin re- 
sistance. (b) Viability of the mutant lamin A-expressing cells af- 
ter 8, 16, 24, and 48 h at 32°C expressed as a percentage of the vi- 
ability at 38°C (0 h). 
cleavage is not involved in the regulation of cell growth or 
cell cycle control. The mutant lamin A-expressing and the 
control cell lines were incubated at 32°C and followed for 
changes in viability. Fig. 6 b shows the percentage viability 
as a  function of the time at 32°C.  Where the  two vector 
control cell lines lost viability rapidly at 32°C as previously 
observed for similarly constructed cell lines (Chiou et al., 
1994a;  Debbas and White,  1993;  Sabbatini et al.,  1995b), 
the  three  independent  mutant  lamin  A-expressing  cell 
lines displayed delayed onset of viability loss, surviving for 
an additional  12-16 h  at 32°C, and instead the viable cell 
number increased (Fig. 6 b). The kinetics of the morpho- 
logical signs associated with apoptosis were delayed for 12 h 
in the mutant lamin A-expressing cells. After 12-16 h  at 
the  permissive temperature,  however,  the  mutant  lamin 
A-expressing  cells  rapidly  lost  viability  and  ultimately 
reached the levels of cell death of the vector control lines 
by 48 h (Fig. 6 b). 
While lamin A/C are encoded by the same gene and dif- 
fer only in their COOH terminus as a result of alternative 
splicing,  lamin  B  is  a  distinct  but  structurally  related 
polypeptide. Lamin B  is expressed early in  development 
and in virtually all somatic cell types (Nigg, 1992). We ex- 
pressed the uncleavable mutant of lamin B in cells to see if 
the attenuation of apoptosis observed with mutant lamin 
A  could also be achieved by preventing lamin B cleavage, 
and to determine if preventing cleavage of both lamin A 
and  B  could  further  augment  survival.  As  with  the  un- 
cleavable lamin A, the  cleavage site mutation of human 
lamin B was reconstituted into the full-length lamin B pro- 
tein, and a FLAG epitope tag was placed at the NH2 ter- 
minus to distinguish  it from both the endogenous lamins 
and the uncleavable lamin A. The mutant lamin B was ex- 
pressed by the cytomegalovirus promoter in a vector with 
a  neomycin selectable marker. This allowed for selection 
of mutant lamin B-expressing clones independent of mu- 
tant lamin A, which was introduced by hygromycin selec- 
tion.  Mutant  lamin B  was  transfected into  a  vector line 
(Vhl) and two mutant lamin A-expressing clones (LA-1 
and LA-2). As the Western blot in Fig. 7 a shows, equiva- 
lent cell lines were selected to express either mutant lamin 
A  (  LAI-n and  LA2-n),  mutant  lamin B  (Vhl-LB1  and 
Vhl-LB2),  or  both  mutants  (LA1-LB1,  LA1-LB2  and 
LA2-LB3).  These  cell  lines  expressed  the  mutant  lamin 
proteins at levels comparable to the level of endogenous 
lamins as detected with anti-myc and -FLAG antibodies 
(Fig. 7 a) or with an anti-lamin mAb (see Fig. 9). The cell 
lines were incubated at 32°C and assessed for the ability of 
the mutant proteins to affect p53-dependent apoptosis. 
Fig.  7,  b  and c, shows the  percentage of viability as a 
function of time for the cell lines expressing mutant lamin 
A  or mutant lamin B, or both mutant lamin A  and mutant 
lamin  B,  and  the  corresponding  control  cell  lines.  The 
19K1 line, which is completely inhibited from cell death as 
a result of E1B 19K expression, serves as a positive control 
(Debbas  and  White,  1993).  Expression  of either  mutant 
lamin A  or mutant lamin B produced a delay in the induc- 
tion of apoptosis by 12-16 h (Fig. 7 b), similar to what was 
observed previously with the mutant lamin A-expressing 
cell lines (Fig. 6 b). Mutant lamin A  expression appeared 
to  be  more  effective at  delaying  apoptosis  than  mutant 
lamin B  expression (Fig. 7 b). Expression of both mutant 
lamin A  and lamin B in the same cell was not additive. Vi- 
ability of the  cell lines  expressing both  mutant  lamin A 
and  lamin  B  (LA1-LB1,  LA1-LB2,  and  LA2-LB3)  fol- 
lowed the same course as with cell lines expressing either 
mutant lamin A  or lamin B  alone  (LAI-n, LA2-n, Vhl- 
LB1,  and  Vhl-LB2),  and  cell  death  was  attenuated  by 
12-16  h  (Fig.  7  c).  The  vector control lines  (Vhl-nl  and 
Vhl-n2)  (Fig. 7,  b  and c) gradually lost viability, and the 
cytopathic effects associated with apoptosis were evident 
after 12 h at 32°C (data not shown). E1B 19K expression in 
the 19K1 cell line completely overcame apoptosis, and the 
cells were diverted to p53-dependent growth arrest (Fig. 7 
c) as previously reported (Sabbatini et al., 1995a). The lim- 
ited  protection  afforded by uncleavable lamins does not 
seem to depend on increased protein expression, since no 
correlation was observed between levels of expression of 
the mutant proteins and attenuation of apoptosis (Fig. 7; 
data for other clones not shown). The overall effect, dem- 
onstrated with eight independent cell lines expressing un- 
cleavable mutants of the nuclear lamins, was to delay the 
onset of cell death. Thus, lamin cleavage facilitates the ap- 
optotic process, perhaps by promoting nuclear destruction. 
Similar results were observed when the  same panel of 
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pression of the cleavage site 
mutants of lamin A and lamin 
B attenuates the induction of 
p53-dependent apoptosis. (a) 
Selection of cell lines for mu- 
tant  lamin  B  expression. 
Western blot shows indepen- 
dent cell lines selected to ex- 
press  neither  mutant  lamin 
protein,  mutant  lamin  A  or 
lamin  B,  or  both  mutant 
lamin A  and  lamin B.  Blots 
were  probed  with  anti-myc 
and -FLAG epitope antibod- 
ies  for  detecting  mutant 
lamin A and mutant lamin B, 
respectively. (b) Viability of the cell lines expressing only mutant lamin A or lamin B (LAI-n, LA3-n, Vhl-LB1, and Vhl-LB2) after 8, 
16, 24, and 48 h at 32°C expressed as a percentage of the viability at 38°C (0 h). (c) Viability of the cell lines expressing both mutant 
lamin A and lamin B (LA1-LB1, LA1-LB2, and LA2-LB3) at 8, 16, 24, and 48 h after incubating at 32°C expressed as a percentage of 
the viability at 38°C (0 h). 19K1 is an E1B 19K-expressing cell line that is resistant to apoptosis (Debbas and White, 1993). The vector 
controls in all viability graphs are represented by open boxes and circles. 
cell lines was induced  to undergo  apoptosis  by treatment 
with actinomycin D  (data not shown).  Actinomycin D  in- 
duces  a  p53-independent  pathway,  as  apoptosis  is  effi- 
ciently  induced  when  the  cells  are  maintained  at the  re- 
strictive  temperature  of  38°C  (Sabbatini  et  al.,  1995a). 
Therefore,  preventing  the  proteolytic  degradation  of the 
nuclear  lamina  by ICE-related  cysteine proteases  affords 
significant  but  limited protection  from apoptosis  induced 
by two independent means. 
viability  loss  in  both  the  vector  control  and  the  mutant 
lamin-expressing  cell lines  (Figs. 7  c  and 8). These  results 
suggest  a  function  for lamin proteolysis in facilitating the 
activation of the nucleases responsible for DNA fragmen- 
Onset of DNA Fragmentation Is Dependent on Lamin 
Cleavage In Vivo 
Activation  of  nucleases  is  a  downstream  nuclear  event 
during  apoptosis  as  evidenced  from  oligonucleosomal 
cleavage  of DNA  characteristic  of apoptosis  (Earnshaw, 
1995).  DNA  fragmentation  accompanies  loss  of viability 
during  EiA-induced  p53-dependent  apoptosis  (Debbas 
and  White,  1993).  The  degradation  of lamin  B1  in  apop- 
totic thymocytes precedes  DNA  fragmentation  (Neamati 
et al.,  1995),  and  inhibition  of lamin proteases  by TLCK 
does not prevent internucleosomal  cleavage of DNA  (La- 
zebnik  et  al.,  1995).  These  observations  suggest  that  the 
activation  of  nucleases  is  independent  of  the  proteases 
during apoptosis. 
The delay in the onset of apoptosis observed in mutant 
lamin-expressing  cells  indicated  a  role  in  bringing  about 
the downstream nuclear events of apoptosis. Low molecu- 
lar weight DNA was isolated from a vector control cell line 
(Vhl-n2)  and two representative  mutant  lamin-expressing 
cell  lines  (LA1-LB1  and  LA1-LB3)  incubated  at  32°C 
(0 h) and for 8, 16, 24, and 48 h  at 32°C. After 8 h  at 32°C, 
coincident with viability loss, cleavage of DNA into oligo- 
nucleosomal-size  fragments  was  observed  in  the  vector 
control cell line (Fig. 8). The time course of DNA fragmen- 
tation  in  the  mutant  lamin-expressing  cell  line  followed 
the  delay in the loss of viability observed earlier, with no 
DNA degradation at 8 h and progressively increasing at 16 
and  24 h  and  reflecting  the  vector control  levels by 48  h 
(Fig. 8). The DNA fragmentation pattern closely followed 
Figure 8.  Delay in the induction  of DNA fragmentation in the 
mutant lamin-expressing cells. Integrity of DNA was determined 
in a vector control cell line (Vhl-n2) and two representative mu- 
tant  lamin-expressing  cell  lines  (LA1-LB1  and  LA1-LB3)  at 
38°C (0 h) and after 8, 16, 24, and 48 h at 32°C. Low molecular 
weight DNA was isolated, resolved by electrophoresis on a  1% 
agarose gel, and visualized with ethidium bromide. 
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be required to render the nucleases accessible to proteases 
or other agents that bring about their activation. 
Kinetics of  PARP  and Lamin Cleavage In Vivo 
In parallel with viability, cell extracts were prepared from 
a  vector  control  cell  line  (Vhl-n2),  two  mutant  lamin 
A- and lamin B-expressing cell lines (LA1-LB1 and LA2- 
LB3), and the E1B 19K-expressing cell line (19K1). West- 
ern  blot  analysis  was  used  to  detect  PARP  and  lamin 
cleavage during p53-dependent apoptosis. PARP cleavage 
from a  116- to 85-kD fragment was observed 8 h after in- 
cubation at 32°C with all cell lines except the EIB 19K- 
expressing  cell  line,  19K1  (Fig.  9).  Therefore,  mutant 
lamin  expression  does  not  alter  the  activation  of  ICE- 
related PARP cysteine protease, as would be expected. No 
PARP cleavage was apparent in the E1B 19K-expressing 
cells at any time point  (Fig. 9).  Cleavage of endogenous 
lamin A/C was observed at the 8-h time point as indicated 
by the  generation  of the  lamin A  p47  and  lamin C  p37 
polypeptides  (Fig.  9).  The  kinetics of endogenous  lamin 
cleavage in the mutant lamin-expressing cells was slightly 
delayed with less degradation products apparent at 8 h. At 
later times the  degradation products were  clearly distin- 
guishable  and  identical  to  the  controls  (Fig.  9).  Nuclear 
lamins are known to polymerize and assemble to form the 
nuclear lamina  in  association with  the  nuclear  envelope 
(Nigg, 1992). It is possible that the overexpressed cleavage 
site  lamin  mutants  copolymerize  with  the  endogenous 
lamins  and  thereby  protect  the  endogenous  lamin  A/C 
from proteolysis. The lamin A  and lamin B  cleavage site 
mutants, on the contrary, were completely resistant to pro- 
teolysis or degradation as seen in Western blots with anti- 
myc and  -FLAG epitope antibodies  (Fig.  9).  Some non- 
specific proteolysis of mutant lamin B was seen after 48 h 
of incubation at the permissive temperature when cell via- 
bility was very low. Actin serves as a  control for protein 
loading (Fig. 9). 
These results indicated that first, the attenuation of apop- 
tosis observed upon mutant lamin expression (Fig. 7 c) was 
the result of events that occurred downstream of protease 
activation;  secondly, cleavage of PARP proceeded inde- 
pendently of lamin cleavage; and finally, the cleavage-site 
lamin mutants were  resistant  to protease action in  vivo, 
confirming that  the  site  altered  by mutagenesis was  the 
site of lamin proteolysis. 
Ultrastructural and Morphological Analysis of the 
Mutant Lamin-expressing Cells 
Despite the delay in the onset of apoptosis, mutant lamin- 
expressing cells lost viability after 18 h at 32°C and showed 
gross  morphological  alterations  indicative  of  apoptosis 
similar to the vector control cells. Ultrastructural analysis 
was performed to document the nuclear events occurring 
during apoptosis in the presence and absence of uncleav- 
able  lamins.  Vhl-nl  cells  at  38°C  were  ultrastructurally 
normal (Fig. 10 a) and no different in appearance from cell 
lines expressing mutant lamin A  and B (LA1-LB1) at 38°C 
(data not  shown).  Higher magnification (20,000)  showed 
an intact and well-defined  lamina with an even distribu- 
tion of nuclear pores (Fig.  10 b). The vector control cells 
examined after 24-h incubation at 32°C were morphologi- 
cally apoptotic at the level of the light microscope when 
the majority of the cell population was detached and the 
viability  was  low  (see  Fig.  7  c).  Electron  micrographs 
showed  these  cells  to  have  a  hollow  nucleus  with  con- 
densed chromatin (Fig. 10 c), and the lamina was less ap- 
parent at the nuclear periphery, although the nuclear en- 
velope appeared intact  (Fig.  10 d)  as has been observed 
previously (Wyllie,  1980).  In contrast,  >40%  of the  mu- 
tant  lamin-expressing  cells  had  a  striking  phenotype, 
whereby the lamina remained intact (Fig. 10f) and the nu- 
Figure 9.  Cleavage-site  mu- 
tants  of lamins  are  not  de- 
graded  in  vivo  during  p53- 
dependent  apoptosis.  West- 
ern blot analysis  of Vhl-n2, 
LA1-LB1,  LA1-LB3,  and 
19K1 cells. Cell extracts were 
obtained in parallel with via- 
bility estimations  (Fig. 7 c) at 
the  restrictive  temperature 
(0 h) and after incubating  at 
the  permissive  temperature 
for 8, 16, 24, and 48 h. Blots 
were probed with antibodies 
specific  for PARP  (C-2-10), 
lamin A/C, the myc epitope 
tag to detect mutant lamin A, 
the FLAG epitope tag to de- 
tect mutant lamin B, and ac- 
tin. The position of the cleav- 
age  product  for  PARP  is 
indicated  as  p85,  and  for 
lamin  A  and  C  as  LA p47 
and  LC  p37,  respectively. 
Actin served as a control for 
protein loading. 
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EM after incubation at 32°C for 24 h (e and f). Control lines at 38°C (a and b) or after 24 h at 32°C (c and d) were also processed simul- 
taneously. The exact region magnified is boxed in the lower magnification image. (Arrows) Regions of degrading lamina. 
cleus involuted (Fig.  10 e). Higher magnification showed 
an electron-dense lamina still intact and underlying a con- 
voluted nuclear envelope (Fig. 10f). 
Indirect immunofluorescence was performed on the mu- 
tant lamin A- and lamin B-expressing cells and the vector 
control cells to examine the morphology of the nucleus and 
the status of the mutant lamins as the cells were undergo- 
ing apoptosis. Staining with antibodies directed against the 
myc epitope to visualize mutant lamin A (Fig. 11) and with 
the FLAG epitope to visualize mutant lamin B  (data not 
shown) revealed bright staining of the lamina as a result of 
the expression of the mutant proteins. The mutant lamin 
proteins  localized to  the  nuclear  envelope in  a  staining 
pattern  that  was  indistinguishable  from the  endogenous 
lamins  (Fig.  2).  Hoechst dye staining  to  visualize  DNA 
showed condensed chromatin along the periphery of the 
nucleus in  apoptotic cells of the  vector control cell line 
(Vhl-nl)  (Fig. 11). On the contrary, the mutant lamin- 
expressing  cells  reflected the  observations  made  from 
ultrastructural  analysis.  In  >50%  of the  cells  that  had 
rounded  up  and  appeared  to  be  apoptotic,  staining  the 
DNA  with  Hoechst  dye  showed  convoluted  structures 
with DNA lining the nuclear periphery (Fig. 11). The mu- 
tant lamin stained brightly in these cells, indicating their 
resistance to proteolysis (Fig. 11). The DNA appeared to 
localize at the lamina, and the absence of any cells showing 
signs  of  classical  chromatin  condensation  was  striking. 
These  observations  confirm  the  morphology  reported 
when lamin proteolysis was  inhibited in  vitro by TLCK 
(Lazebnik et al., 1995), where the chromatin formed a con- 
tinuous rim around the periphery of the nucleus in cell- 
free extracts. However, the terminal morphology assessed 
by Hoechst dye staining of the floating cells at 28 h was in- 
variant between the mutant lamin A- and lamin B-express- 
ing cells  and  the  corresponding controls.  DNA  staining 
clearly showed the formation of apoptotic bodies in both 
populations (Fig. 11). Thus, the formation of the late stage 
(terminal)  phenotype  of apoptotic cell  death  was  unal- 
tered by inhibiting lamin cleavage in vivo. 
In summary, expression of the uncleavable mutants  of 
lamins resistant to proteolysis in vivo delayed cell death 
and conferred altered morphology to the cells when they 
did  undergo  apoptosis.  A  protease-resistant  lamina  pre- 
vented the chromatin from condensing against the periph- 
ery of the nucleus and caused the convolution of the nu- 
cleus along the lamina carrying the nuclear envelope with it. 
This suggests a role for lamin proteolysis in bringing about 
some of the nuclear changes observed during apoptosis. 
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the mutant lamin-expressing 
cells. The expression  of mu- 
tant lamin  A  was visualized 
by immunofluorescence stain- 
ing with anti-myc epitope an- 
tibodies  after incubating  the 
cells at 32°C for 24 h. Vector 
control lines were processed 
in  parallel.  Hoechst  dye 
staining was also done to vi- 
sualize  DNA.  Photographs 
are  in  two  planes  of focus 
with the apoptotic cells indi- 
cated  by  arrows.  (Bottom 
panel)  Terminal  phenotype 
as seen in the floating cells by 
in situ staining with Hoechst 
dye.  (Arrows) Representa- 
tive cells with distinct apop- 
totic bodies. 
Discussion 
Apoptosis  induced  by  adenovirus  E1A  displays  all  the 
classical  morphological events  of apoptosis  (Rao  et  al., 
1992; White et al.,  1992; Wyllie, 1980). Furthermore, the 
EIB 19K protein is the adenoviral equivalent of the mam- 
malian protooncogene product Bcl-2 and inhibits apopto- 
sis to maximize viral yield (Chiou et al., 1994b) and to pro- 
mote transformation  (Rao  et al.,  1992).  This argues for 
conserved genetic elements in apoptosis present in varied 
systems ranging from viruses to mammals. It is therefore 
conceivable that  the  biochemical pathways  and  mecha- 
nisms of the process are also conserved. In fact, induction 
of the Bcl-2 antagonist, Bax, is a biochemical event down- 
stream of p53 that promotes EiA-induced apoptosis (Han 
et al., 1996a). Activation of the ICE family of cysteine pro- 
teases is another biochemical event that occurs during apop- 
tosis that has been preserved through evolution (Martin 
and  Green,  1995;  Whyte  and  Evan,  1995;  Yuan  et  al., 
1993). Processing of CPP32, a  representative member of 
the ICE family, has been observed during p53-dependent 
apoptosis and requires a  transcriptionally competent p53 
(Sabbatini, P., J. Han, S.-K. Chiou, D.W. Nicholson, and 
E.  White,  manuscript  in  preparation).  Activation of the 
lamin protease and the site-specific cleavage of lamins ob- 
served in this study is further testimony to the activation of 
ICE-related cysteine proteases downstream of p53. ICE- 
related protease  activation could be  a  direct or indirect 
consequence of Bax induction. The EIB 19K protein func- 
tions as an apoptosis inhibitor in BRK cells by physically 
complexing  with  the  death-inducing  proteins  Bax  and 
Nbk/Bik (Han et al., 1996a, b). Absence of any lamin deg- 
radation  or  activation  of lamin  proteases  in  E1B  19K- 
expressing cells places the 19K protein upstream of pro- 
tease activation in the pathway. Activation of CPP32 and 
cleavage of PARP is observed when p53 null cells are in- 
fected with 19K- viruses expressing only E1A (Boulakia 
et al., 1996). Coexpression of E1B 19K can prevent activa- 
tion of CPP32 and cleavage of PARP in both p53-depen- 
dent  and  -independent situations  (Boulakia et  al.,  1996; 
Sabbatini, P., J. Han, S.-K. Chiou, D.W. Nicholson, and E. 
White, manuscript in preparation). Bax and Nbk may rep- 
resent the p53-dependent and -independent upstream ele- 
ments, respectively, for bringing about protease activation. 
The E1B 19K protein is able to effectively inhibit both of 
these cytotoxic proteins by interactions via the BH3 do- 
main (Boyd et al., 1995; Han et al., 1996a,b). CPP32 does 
not cleave lamins in vitro, and activation of parallel pro- 
teinase  pathways  has  been  proposed  (La~bnik  et  al., 
1995). Therefore, it appears that at least two proteases are 
activated  either  in  parallel  or  in  tandem  during  E1A- 
induced apoptosis. This suggests that the E1B 19K protein 
potently inhibits apoptosis by functioning far upstream to 
prevent the biochemical process leading to the activation 
of multiple cysteine proteases. 
The site of lamin cleavage was mapped to a conserved 
aspartate residue at position 230 and has been confirmed 
with mutational analysis both in  vitro and  in vivo. This 
lamin cleavage site was mapped to the same aspartate resi- 
due independently by different methods (Takahashi et al., 
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rod domain of all three types of lamins. The a-helical rod 
domain is important for dimerization and higher order as- 
sembly of the  lamina  (McKeon,  1991). The presence of 
specific chromatin binding  sites  in  this  domain has  also 
been demonstrated (Glass et al.,  1993). Cleavage at this 
site  may represent  an  effective mechanism  of breaking 
down the lamina and releasing the chromatin at specific 
sites to assist condensation and packaging into apoptotic 
bodies. A  second cleavage site at position 446 in the con- 
text of a consensus cleavage site is not recognized by the 
lamin protease. Also, lamin A is specifically cleaved by the 
ICE-like proteases  Mch-2a  but not  CPP32  (Orth et al., 
1996; Takahashi et al., 1996). This type of specificity be- 
tween  enzymes, substrates,  and  the  cleavage site  could 
come from availability of the  site for proteolysis in the 
three-dimensional structure of the protein and/or the con- 
text of the  cleavage  site  in  relation to  the  surrounding 
amino acid sequence. 
PARP, as a substrate, has become an indicator for cys- 
teine proteases activated during apoptosis (Lazebnik et al., 
1994). The relevance of PARP as a substrate in vivo ap- 
pears limited, as knocking out the gene results in specific 
defects in ribosylation with otherwise normal mice (Wang 
et al., 1995). Lamins may be more relevant in vivo as a re- 
sult of their role in maintenance of the structural elements 
that  hold  the  nucleus  together.  Lamin  degradation  and 
breakdown has been reported in different cell types and in 
response to different apoptosis-inducing stimuli (Neamati 
et al., 1995; Oberhammer et al., 1994; Ucker et al., 1992). 
Furthermore, the  attenuation of cell death we  have ob- 
served upon expressing uncleavable lamins implicates the 
lamins  as  key substrates  targeted  for degradation  rela- 
tively early in the apoptotic process. The degradation of 
lamin B1 has been reported to precede DNA fragmenta- 
tion in thymocytes undergoing apoptosis (Neamati et al., 
1995). Inhibition of lamin proteinases does not prevent in- 
ternucleosomal DNA cleavage in the cell-free system with 
HeLa nuclei (Lazebnik et al.,  1995). In vivo we have ob- 
served DNA fragmentation to be delayed in the mutant 
lamin-expressing cells, indicating that activation of the nu- 
cleases functional during apoptosis is dependent on break- 
down of the lamina and overall nuclear disintegration. The 
in vitro results reflect an end point analysis when the nu- 
cleases are active (Lazebnik et al., 1995), as we have ob- 
served. However, kinetic analysis of DNA fragmentation 
in the mutant lamin-expressing cells indicated a  delay in 
the  activation of nucleases during apoptosis.  Obviously, 
preventing lamin cleavage is not sufficient to inhibit apop- 
tosis, as subsequent events take over and bring about cell 
death. The attenuation of apoptosis observed here is sig- 
nificant in establishing the sequence of events downstream 
of protease activation. Inhibiting lamin cleavage prevents 
loss  of cell  viability  until  perhaps  proteolytic attack  of 
other  substrates  promotes  nuclear  degradation  and  the 
cell succumbs. 
Clues to the role of lamin proteolysis in apoptosis have 
come from the ultrastructure and morphological analysis 
of these cells expressing uncleavable mutant lamins. Al- 
though the cells expressing mutant lamins lose viability, 
their lamina remains intact and assumes a convoluted ap- 
pearance (Fig. 12). The shrinkage of nuclei seen in control 
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Figure 12.  Model for the possible role of the lamina during apop- 
tosis. Schematic model to explain the observations made, indicat- 
ing a role for lamin degradation  in the execution of cell death 
processes. 
cells undergoing apoptosis is markedly absent in the mu- 
tant  lamin-expressing cells.  Instead,  collapse of the  nu- 
clear envelope with the lamina is observed in the absence 
of chromatin condensation (Fig. 12).  Lazebnik et al.  have 
reported a similar inability of the chromatin to condense 
upon inhibiting lamin proteases in vitro (Lazebnik et al., 
1995). The reflection of this phenomenon in vivo suggests 
a role for lamin proteolysis in the nuclear events of apop- 
tosis. 
There  are  three,  not  necessarily  mutually  exclusive, 
models to account for a role of lamin cleavage in apoptosis 
that are consistent with our observations. First, inhibiting 
lamin proteolysis may prevent detachment of DNA at the 
sites where it contacts the lamina, since lamins serve to an- 
chor and to organize chromatin at the nuclear periphery. 
This would result in the inability of the chromatin to con- 
dense into discrete packages; instead, the DNA would col- 
lapse against the periphery of the nucleus. Hollowing of 
the nucleus, in addition to the stress created by the chro- 
matin still attached to the lamins, may cause the lamina to 
involute along with the  nuclear membranes.  Second, an 
uncleavable lamina may prevent the shrinkage of nuclei 
imposing an additional restriction. Thus, the proteolysis of 
lamins allows for condensation of the chromatin into ag- 
gregates for rapid packaging into membrane-bound apop- 
totic bodies. Third, lamin breakdown may facilitate nuclear 
breakdown by opening up the nucleus and permitting deg- 
radation of other nuclear substrates as well as rendering 
the nucleases accessible to activation by cytoplasmic fac- 
tors. In conclusion, the lamins represent a  key substrate 
for the proteases activated during apoptosis whose degra- 
dation facilitates the nuclear events of apoptosis. 
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